Malaysiakini

US FDA set to authorise Pfizer Covid-19 shot for ages 12-15: NYT

Reuters

Published

The US Food and Drug Administration (US FDA) is preparing to authorise Pfizer Inc and German partner BioNTech SE's Covid-19 vaccine for adolescents aged between 12 and 15 years by early next week, the New York Times reported on Monday, citing federal officials familiar with the agency's plans.

An approval is highly anticipated after the drugmakers said in March that the vaccine was found to be safe, effective and produced robust antibody responses in 12 to 15-year-olds in a clinical trial...

All Access Plan
starting from

~RM12

per month
Subscribe Now
You can cancel anytime.
Get unlimited access to our articles on web and apps
Add comments to our articles
Bookmark articles to read later
We accept
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In